Halozyme Therapeutics shares owned by Duality Advisers
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Duality Advisers
from 13F filings
Historical chart of Duality Advisers investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Duality Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Duality Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $1.1M | 26k | 40.68 |
| 2023-12-31 | $2.0M | 53k | 36.96 |
| 2023-09-30 | $1.5M | 40k | 38.20 |
| 2023-06-30 | $555k | 15k | 36.07 |
| 2023-03-31 | $2.6M | 69k | 38.19 |
| 2022-12-31 | $2.1M | 38k | 56.90 |
| 2022-03-31 | $483k | 12k | 39.87 |
| 2021-09-30 | $3.7M | 91k | 40.68 |
| 2021-03-31 | $830k | 20k | 41.69 |
| 2020-09-30 | $1.1M | 41k | 26.28 |
| 2020-06-30 | $887k | 33k | 26.82 |
| 2019-12-31 | $396k | 22k | 17.73 |
More positions owned by Duality Advisers
View all positions for Duality Advisers